Search research articles
Contact Us
Filters
Showing results (731-740 of 1,008) with videos related to
Page
of 101
Sort By:
American Journal of Public Health
|
March 22, 2019
Association of State Dense Breast Notification Laws With Supplemental Testing and Cancer Detection After Screening Mammography
Susan H Busch, Jessica R Hoag, Jenerius A Aminawung, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
January 13, 2006
Renoprotective effect of a dopamine D3 receptor antagonist in experimental type II diabetes
Marie-Luise P Gross, Andreas Koch, Bernd Mühlbauer, et al.
Current Biology : CB
|
April 14, 2009
Enhanced arrestin facilitates recovery and protects rods lacking rhodopsin phosphorylation
Xiufeng Song, Sergey A Vishnivetskiy, Owen P Gross, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
December 1, 2023
Melt crystallization and thermal degradation profile of the antichagasic drug nifurtimox
Idejan P Gross, Ana Luiza Lima, Giselle R Bedogni, et al.
Obstetrics and Gynecology
|
March 13, 2018
Occult Gynecologic Cancer in Women Undergoing Hysterectomy or Myomectomy for Benign Indications
Vrunda B Desai, Jason D Wright, Peter E Schwartz, et al.
Plos Medicine
|
December 2, 2005
Are racial and ethnic minorities less willing to participate in health research?
David Wendler, Raynard Kington, Jennifer Madans, et al.
JCO Oncology Practice
|
June 10, 2025
Representation of Women, Older Adults, and Racial and Ethnic Minoritized Patients in Pivotal Trials for US Food and Drug Administration Novel Oncology Therapeutic Approvals, 2012-2021: Bright Spot Trials and Trends Over Time
Jennifer E Miller, William Pelletiers, Cary P Gross, et al.
American Heart Journal
|
August 2, 2003
Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure
Frederick A Masoudi, Edward P Havranek, Pam Wolfe, et al.
JAMA Network Open
|
May 5, 2021
Evaluation of Drug Trials in High-, Middle-, and Low-Income Countries and Local Commercial Availability of Newly Approved Drugs
Jennifer E Miller, Michelle M Mello, Joshua D Wallach, et al.
JAMA Network Open
|
June 9, 2020
Association of Programmed Cell Death Ligand 1 Expression Status With Receipt of Immune Checkpoint Inhibitors in Patients With Advanced Non-Small Cell Lung Cancer
Michael S Leapman, Carolyn J Presley, Weiwei Zhu, et al.
Page
of 101
Search research articles
Search
Showing results (731-740 of 1,008) with videos related to
Sort By:
Page
of 101
American Journal of Public Health
|
March 22, 2019
Association of State Dense Breast Notification Laws With Supplemental Testing and Cancer Detection After Screening Mammography
Susan H Busch, Jessica R Hoag, Jenerius A Aminawung, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
January 13, 2006
Renoprotective effect of a dopamine D3 receptor antagonist in experimental type II diabetes
Marie-Luise P Gross, Andreas Koch, Bernd Mühlbauer, et al.
Current Biology : CB
|
April 14, 2009
Enhanced arrestin facilitates recovery and protects rods lacking rhodopsin phosphorylation
Xiufeng Song, Sergey A Vishnivetskiy, Owen P Gross, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
December 1, 2023
Melt crystallization and thermal degradation profile of the antichagasic drug nifurtimox
Idejan P Gross, Ana Luiza Lima, Giselle R Bedogni, et al.
Obstetrics and Gynecology
|
March 13, 2018
Occult Gynecologic Cancer in Women Undergoing Hysterectomy or Myomectomy for Benign Indications
Vrunda B Desai, Jason D Wright, Peter E Schwartz, et al.
Plos Medicine
|
December 2, 2005
Are racial and ethnic minorities less willing to participate in health research?
David Wendler, Raynard Kington, Jennifer Madans, et al.
JCO Oncology Practice
|
June 10, 2025
Representation of Women, Older Adults, and Racial and Ethnic Minoritized Patients in Pivotal Trials for US Food and Drug Administration Novel Oncology Therapeutic Approvals, 2012-2021: Bright Spot Trials and Trends Over Time
Jennifer E Miller, William Pelletiers, Cary P Gross, et al.
American Heart Journal
|
August 2, 2003
Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure
Frederick A Masoudi, Edward P Havranek, Pam Wolfe, et al.
JAMA Network Open
|
May 5, 2021
Evaluation of Drug Trials in High-, Middle-, and Low-Income Countries and Local Commercial Availability of Newly Approved Drugs
Jennifer E Miller, Michelle M Mello, Joshua D Wallach, et al.
JAMA Network Open
|
June 9, 2020
Association of Programmed Cell Death Ligand 1 Expression Status With Receipt of Immune Checkpoint Inhibitors in Patients With Advanced Non-Small Cell Lung Cancer
Michael S Leapman, Carolyn J Presley, Weiwei Zhu, et al.
Page
of 101